Healthcare
Tuesday, September 6, 2016
BRIEF-Anhui Anke Biotechnology Group to acquire PD-1 humanized antibody and related technologies at 50 mln yuan
* Says it will acquire PD-1 (Programmed death 1) humanized
antibody and related technologies from a Shanghai-based
pharmaceutical science and technology company at 50 million yuan
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment